Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis
Open Access
- 3 March 2026
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 24 (3) , 100
Abstract
Developing novel anabolic agents for bone regeneration remains a clinical priority. Polydeoxyribonucleotide (PDRN) exhibits tissue-regenerative properties, but its direct cellular effects on bone remodeling remain unclear. This in vitro study investigated PDRN’s effects on osteoblast (MC3T3-E1) and osteoclast (primary bone marrow-derived macrophages) differentiation. We evaluated metabolic activity, gene/protein expression, and specific differentiation markers using MTS, qRT-PCR, Western blotting, and functional assays (ALP, Alizarin Red S, TRAP, pit formation). In osteoblasts, PDRN dose-dependently modulated metabolic activity while upregulating the early transcription factor Runx2. PDRN significantly enhanced osteoblast differentiation, evidenced by increased ALP activity, elevated mineralized matrix deposition, and robust upregulation of osteocalcin and Runx2. Conversely, PDRN exhibited no direct effect on osteoclast precursor metabolic activity, differentiation, or resorptive function. These findings support a working hypothesis in which PDRN selectively promotes osteoblast differentiation without directly affecting osteoclastogenesis. While further pharmacological investigations are required to definitively elucidate the specific purinergic receptor mechanisms, our results highlight PDRN as a promising candidate anabolic agent for bone regeneration.Keywords
Funding Information
- Kyungpook National University Hospital
This publication has 44 references indexed in Scilit:
- Adenosine Kinase: An Epigenetic Modulator and Drug TargetJournal of Inherited Metabolic Disease, 2025
- Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systemsAgeing Research Reviews, 2025
- NPP1 and TNAP hydrolyze ATP synergistically during biomineralizationPurinergic Signalling, 2022
- Osteoblast-like MC3T3-E1 Cells Prefer Glycolysis for ATP Production but Adipocyte-like 3T3-L1 Cells Prefer Oxidative PhosphorylationJournal of Bone and Mineral Research, 2018
- Connexin43 and Pannexin1 Channels in Osteoblasts: Who Is the “Hemichannel”?The Journal of Membrane Biology, 2012
- Adenosine A2A Receptor Ligation Inhibits Osteoclast FormationThe American Journal of Pathology, 2012
- On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cellsJournal of Cellular Physiology, 2010
- Effect of polydeoxyribonucleotides on human fibroblasts in primary cultureCell Biochemistry and Function, 1999
- Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrixJournal of Cellular Physiology, 1990
- Osteotropic agents induce the differential secretion of granulocyte-macrophage colony-stimulating factor by the osteoblast cell line MC3T3-E1Journal of Bone and Mineral Research, 1989